Josef S Smolen Selected Research

Pain (Aches)

12/2023	Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023.
11/2021	What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study.
12/2020	Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries.
1/2020	Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study.
9/2019	Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial.
1/2019	Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial.
12/2018	Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial.
12/2018	Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?
1/2018	Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis.
1/2017	Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josef S Smolen Research Topics

Disease

189	Rheumatoid Arthritis 11/2023 - 03/2002
45	Arthritis (Polyarthritis) 03/2024 - 01/2002
44	Necrosis 12/2023 - 04/2003
39	Psoriatic Arthritis 03/2024 - 07/2002
27	Inflammation (Inflammations) 01/2023 - 03/2002
24	Infections 01/2023 - 11/2004
24	Rheumatic Diseases (Rheumatism) 01/2021 - 01/2007
22	Pain (Aches) 12/2023 - 11/2002
20	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2002
9	Neoplasms (Cancer) 01/2023 - 06/2010
9	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 03/2002
8	Herpes Zoster 01/2023 - 01/2019
8	Ankylosing Spondylitis 01/2022 - 07/2002
7	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 11/2012
7	Lupus Nephritis 10/2023 - 10/2004
7	Fatigue 12/2020 - 03/2012
6	Disease Progression 12/2023 - 11/2002
6	Synovitis 12/2023 - 01/2008
6	Joint Diseases (Joint Disease) 01/2020 - 04/2003
6	Bone Resorption 01/2010 - 07/2002
5	COVID-19 02/2023 - 01/2022
5	Pneumonia (Pneumonitis) 01/2017 - 11/2004
4	Connective Tissue Diseases (Connective Tissue Disease) 01/2023 - 12/2007
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023 - 04/2013
4	Osteoarthritis 01/2022 - 09/2007
4	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 08/2005
4	Chronic Disease (Chronic Diseases) 09/2019 - 01/2017
3	Cytokine Release Syndrome 01/2023 - 01/2022
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2009
3	Proteinuria 01/2020 - 10/2004
3	Nephritis 01/2017 - 10/2004
3	Mixed Connective Tissue Disease (MCTD) 07/2011 - 08/2005
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2023 - 11/2023
2	Axial Spondyloarthritis 12/2023 - 01/2023
2	Atopic Dermatitis (Atopic Eczema) 11/2023 - 11/2020
2	Body Weight (Weight, Body) 10/2023 - 01/2019

Drug/Important Bio-Agent (IBA)

57	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 10/2004
47	Antirheumatic Agents (DMARD)IBA 03/2024 - 04/2002
29	Adalimumab (Humira)FDA Link 01/2023 - 04/2003
28	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 03/2002
26	Infliximab (Remicade)FDA Link 01/2023 - 10/2004
22	baricitinibIBA 01/2023 - 01/2014
21	GlucocorticoidsIBA 08/2023 - 02/2005
20	Tumor Necrosis Factor InhibitorsIBA 03/2023 - 01/2003
20	AutoantibodiesIBA 01/2023 - 03/2002
19	tocilizumab (atlizumab)FDA Link 01/2023 - 12/2007
18	CytokinesIBA 12/2023 - 11/2002
18	Biosimilar PharmaceuticalsIBA 01/2023 - 03/2013
17	Etanercept (Enbrel)FDA Link 01/2023 - 05/2005
14	tofacitinibIBA 01/2023 - 01/2014
14	C-Reactive ProteinIBA 01/2022 - 07/2002
12	Rituximab (Mabthera)FDA Link 01/2023 - 07/2007
12	Abatacept (Orencia)FDA Link 01/2023 - 07/2007
11	Leflunomide (Arava)FDA LinkGeneric 01/2023 - 06/2004
11	Interleukin-6 (Interleukin 6)IBA 01/2023 - 03/2008
11	golimumab FDA Link 01/2023 - 07/2009
10	Ustekinumab (CNTO 1275)FDA Link 10/2023 - 09/2015
10	ametantrone (HAQ)IBA 10/2023 - 04/2007
10	Janus Kinase InhibitorsIBA 01/2023 - 01/2017
10	Certolizumab Pegol FDA Link 01/2023 - 11/2009
9	AntibodiesIBA 01/2021 - 08/2005
7	InterleukinsIBA 03/2024 - 06/2012
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2002
6	Interleukin-12 (IL 12)IBA 01/2023 - 01/2005
6	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2023 - 06/2004
6	Monoclonal AntibodiesIBA 12/2022 - 11/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2006
6	Janus KinasesIBA 10/2020 - 06/2017
6	Rheumatoid FactorIBA 01/2018 - 11/2002
5	upadacitinibIBA 01/2023 - 12/2016
5	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2022 - 12/2007
5	apremilastIBA 01/2022 - 01/2014
5	ixekizumabIBA 01/2022 - 01/2020
5	Prostaglandins AIBA 01/2020 - 09/2012
5	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2020 - 01/2005
4	Interleukin-1 (Interleukin 1)IBA 07/2022 - 12/2003
4	secukinumabIBA 01/2020 - 09/2015
4	ElementsIBA 08/2017 - 08/2007
4	CollagenIBA 01/2015 - 07/2002
4	AutoantigensIBA 12/2007 - 03/2002
4	OsteoprotegerinIBA 02/2004 - 03/2002
3	EnzymesIBA 11/2023 - 06/2004
3	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2019
3	sarilumabIBA 01/2023 - 06/2017
3	amsonic acid (DAS)IBA 01/2020 - 11/2012
3	Anti-Citrullinated Protein AntibodiesIBA 01/2018 - 09/2010
3	pristane (pristan)IBA 01/2017 - 12/2007
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2008
3	Immunoglobulins (Immunoglobulin)IBA 06/2011 - 12/2007
3	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2006 - 07/2002
2	Interleukin-23 (Interleukin 23)IBA 12/2023 - 05/2017
2	Phosphates (Orthophosphate)IBA 12/2023 - 07/2004
2	ChemokinesIBA 11/2023 - 01/2019
2	ImmunosorbentsIBA 11/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 11/2023 - 12/2022
2	belimumabIBA 10/2023 - 02/2015
2	Tacrolimus (Prograf)FDA LinkGeneric 10/2023 - 01/2020

Therapy/Procedure

104	Therapeutics 03/2024 - 01/2002
6	Aftercare (After-Treatment) 11/2018 - 07/2009
3	Drug Therapy (Chemotherapy) 03/2012 - 07/2004